Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes
暂无分享,去创建一个
R. Klein | T. Ahluwalia | D. Tregouet | A. Galecki | C. Dina | S. Hadjadj | R. Korstanje | B. Klein | C. Forsblom | P. Groop | S. Rich | N. Sandholm | E. Valo | J. Bonventre | T. Orchard | A. Krolewski | P. Rossing | S. Onengut-Gumuscu | J. Mychaleckyj | K. Suszták | M. Pezzolesi | J. Warram | T. Costacou | Rachel G. Miller | A. Smiles | Jingjing Cao | I. Shabalin | Andrew Paterson | J. Haukka | T. Ichimura | Jani K. Haukka | M. Pragnell | H. Keenan | E. Satake | B. Gyorgy | Kristina O’Neil | George L. King | Andrew D. Paterson | R. Klein
[1] M. Hall. National Heart, Lung, and Blood Institute , 2020, The Grants Register 2021.
[2] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[3] J. Bonventre,et al. Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses. , 2019, The Journal of clinical investigation.
[4] Angelo J. Canty,et al. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. , 2019, Journal of the American Society of Nephrology : JASN.
[5] Karsten B. Sieber,et al. Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria , 2019, Nature Communications.
[6] V. M. V. Program. A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019 .
[7] K. Autio,et al. 17B-hydroxysteroid dehydrogenases as acyl thioester metabolizing enzymes , 2019, Molecular and Cellular Endocrinology.
[8] Sushrut S. Waikar,et al. The single-cell transcriptomic landscape of early human diabetic nephropathy , 2019, Proceedings of the National Academy of Sciences.
[9] Samantha A. Morris,et al. Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation with Single-Cell Transcriptomics. , 2018, Cell stem cell.
[10] T. Ahluwalia,et al. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy , 2018, Diabetes Care.
[11] T. Greene,et al. The Familiality of Rapid Renal Decline in Diabetes , 2018, Diabetes.
[12] Christoph Hafemeister,et al. Comprehensive integration of single cell data , 2018, bioRxiv.
[13] Christopher D. Brown,et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease , 2018, Nature Medicine.
[14] Alexander E. Lopez,et al. A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease , 2018, The New England journal of medicine.
[15] T. Orchard,et al. Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset , 2017, Diabetes Care.
[16] Chengxiang Qiu,et al. Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits , 2017, EBioMedicine.
[17] J. Skupień,et al. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. , 2017, Kidney international.
[18] Tom R. Gaunt,et al. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease , 2017, Journal of the American Heart Association.
[19] G. Klebe,et al. First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme. , 2016, Journal of medicinal chemistry.
[20] F. Cunningham,et al. The Ensembl Variant Effect Predictor , 2016, bioRxiv.
[21] K. Shedden,et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker , 2015, Science Translational Medicine.
[22] Inês Barroso,et al. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility , 2015, Nature communications.
[23] A. Kastaniotis,et al. Insights into mitochondrial fatty acid synthesis from the structure of heterotetrameric 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA dehydrogenase , 2014, Nature Communications.
[24] G. Bakris,et al. Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga , 2014, Diabetes Care.
[25] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[26] A. Krolewski,et al. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes , 2014, Clinical and Experimental Nephrology.
[27] A. Krolewski,et al. Diabetic nephropathy: is ESRD its only heritable phenotype? , 2013, Journal of the American Society of Nephrology : JASN.
[28] Lorenz Wernisch,et al. Transcription factor and chromatin features predict genes associated with eQTLs , 2012, Nucleic acids research.
[29] Patrick F. Sullivan,et al. zCall: a rare variant caller for array-based genotyping: Genetics and population analysis , 2012, Bioinform..
[30] Shane J. Neph,et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.
[31] S. Vikingsson,et al. Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues , 2012, Hormone and Metabolic Research.
[32] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[33] D. Zaykin,et al. Optimally weighted Z‐test is a powerful method for combining probabilities in meta‐analysis , 2011, Journal of evolutionary biology.
[34] Xihong Lin,et al. Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.
[35] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[36] S. McNicholas,et al. Presenting your structures: the CCP4mg molecular-graphics software , 2011, Acta crystallographica. Section D, Biological crystallography.
[37] J. Skupień,et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. , 2011, Journal of the American Society of Nephrology : JASN.
[38] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[39] Li Yang,et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury , 2010, Nature Medicine.
[40] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[41] Stephen S. Rich,et al. Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes , 2009, Diabetes.
[42] S. Leal,et al. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.
[43] Song-Yu Yang,et al. HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids. , 2007, Molecular genetics and metabolism.
[44] K. Kavanagh,et al. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. , 2007, The Biochemical journal.
[45] Andrzej S Krolewski,et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. , 2006, Journal of the American Society of Nephrology : JASN.
[46] R. Klein,et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. , 2004, Archives of internal medicine.
[47] H. Parving,et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study , 2004, BMJ : British Medical Journal.
[48] J. Weissenbach,et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.
[49] J. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.
[50] M. Mauer,et al. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? , 2000, Diabetes.
[51] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[52] L. Kuller,et al. Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.
[53] D. Pyke,et al. The genetics of diabetic complications. , 1986, Clinics in endocrinology and metabolism.